Previous 10 |
LEXINGTON, Mass. , March 25, 2019 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that it has entered into an agreement with funds managed by Oberland Capital Manage...
LEXINGTON, Mass. , March 25, 2019 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that the Company will release its fourth quarter and full-year 2018 financial results...
Shares of tiny biotech firm Curis ( CRIS ) have been a disappointment lately, losing more than 80% of their value over the past three years. So far in 2019, the stock has risen by more than 110% as it appears buyers are stepping in and optimism is certainly returning to this small cap name. ...
Curis (NASDAQ: CRIS) is a biotechnology company focused on the development of therapeutics for the treatment of cancer, including fimepinostat, which is being investigated in clinical studies in patients with DLBCL and solid tumors, according to the companies website (see here: www.cu...
LEXINGTON, Mass. , March 4, 2019 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that James Dentzer , President and Chief Executive Officer, will present at the C...
The following slide deck was published by Curis, Inc. in conjunction with this Read more ...
LEXINGTON, Mass. , Feb. 4, 2019 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that James Dentzer , President and Chief Executive Officer, will present at the...
Gainers: Triumph Group (NYSE: TGI ) +27% . ToughBuilt Industries (NASDAQ: TBLT ) +25% . Kazia Therapeutics (NASDAQ: KZIA ) +26% . vTv Therapeutics (NASDAQ: VTVT ) +18% . Xilinx (NASDAQ: XLNX ) +18% . Resonant (NASDAQ: RESN ) +13% . ASLAN Pharmaceuticals (NASDAQ: ASLN ) +16% . ...
LEXINGTON, Mass. , Jan. 24, 2019 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that the first mesothelioma patient has been enrolled and dosed in the Phase I study o...
News, Short Squeeze, Breakout and More Instantly...
Curis to Report Second Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on August 1, 2024 PR Newswire LEXINGTON, Mass. , July 25, 2024 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development ...
2024-07-15 17:46:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Curis to Present at Upcoming Healthcare Conference in July PR Newswire LEXINGTON, Mass. , July 10, 2024 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IR...